SPOP and prostate carcinoma: In this report we demonstrate that a highly sensitive targeted proteomic method, PRISM-SRM (high-pressure, high-resolution separations coupled with intelligent selection and multiplexing—selected reaction monitoring), is capable of providing quantitative information on both wild-type (WT) SPOP and four distinct single amino acid variants of SPOP that have been implicated in prostate cancer.